Page 23 - 83_02
P. 23

Sepsis biomarkers: A review                                       M. Pancreatic Stone Protein/Regenerating Protein
                                                                  Family in Pancreatic and Gastrointestinal Diseases.
69. Ploug M, Rønne E, Behrendt N, Jensen AL, Blasi F,             Intern Med. 2011;50:1507-16.
     Danø K. Cellular receptor for urokinase plasminogen     83. Motoo Y, Satomura Y, Mouri I, Mouri H, Ohtsubo K,
     activator. Carboxyl-terminal processing and                  Sakai J, et al. Serum levels of pancreatitis-associated
     membrane anchoring by glycosyl-                              protein in digestive diseases with special reference to
     phosphatidylinositol. J. Biol. Chem. 1991; 266: 1926–        gastrointestinal cancers. Dig. Dis. Sci. 1999; 44(6):
     33.                                                          1142–7.
                                                             84. Keel M, Härter L, Reding T, Sun L-K, Hersberger M,
70. Eugen-Olsen J. suPAR - a future risk marker in                Seifert B, et al. Pancreatic stone protein is highly
     bacteremia. J Intern Med. 2011;270(1):29–31.                 increased during posttraumatic sepsis and activates
                                                                  neutrophil granulocytes*. Crit. Care Med. 2009;
71. de Kruif MD, Lemaire LC, Giebelen IA, Struck J,               37(5): 1642–8.
     Morgenthaler NG, Papassotiriou J, et al. The influence  85. Que YA, Delodder F, Guessous I, Graf R, Bain M,
     of corticosteroids on the release of novel biomarkers        Calandra T, et al. Pancreatic stone protein as an early
     in human endotoxemia. Intensive Care Med. 2008; 34:          biomarker predicting mortality in a prospective cohort
     518–22.                                                      of patients with sepsis requiring ICU management.
                                                                  Crit. Care. 2012; 16(4): R114.
72. Gustafsson A, Ljunggren L, Bodelsson M, Berkestedt       86. Taylor AL, Llewelyn MJ. Superantigen-Induced
     I. The prognostic value of suPAR compared to other           Proliferation of Human CD4+CD25- T Cells Is
     inflammatory markers in patients with severe sepsis.         Followed by a Switch to a Functional Regulatory
     Biomark Insights. 2012; 7: 39–44.                            Phenotype. J. Immunol. 2010: 185(11): 6591–8.
                                                             87. Rubin LA, Nelson DL. The soluble interleukin-2
73. Schlapbach LJ, Graf R, Woerner A, Fontana M,                  receptor: biology, function, and clinical application.
     Zimmermann-Baer U, Glauser D, et al. Pancreatic              Ann. Intern. Med. 1990: 113(8): 619–27.
     stone protein as a novel marker for neonatal sepsis.    88. Russell SE, Moore AC, Fallon PG, Walsh PT. Soluble
     Intensive Care Med. 2013;39(4):754–63.                       IL-2Ra (sCD25) exacerbates autoimmunity and
                                                                  enhances the development of Th17 responses in mice.
74. Yu D, Kim J, Park C, Park J. Serial Changes of CD4 +          PLoS One. 2012; 7(10): e47748.
     CD25 + FoxP3 + Regulatory T Cell in Canine Model        89. Saito K, Wagatsuma T, Toyama H, Ejima Y, Hoshi K,
     of Sepsis Induced by Endotoxin. J Vet Med Sci.               Shibusawa M, et al. Sepsis is characterized by the
     2014;25:4–7.                                                 increases in percentages of circulating D4+CD25+
                                                                  regulatory T cells and plasma levels of soluble CD25.
75. Matera G, Puccio R, Giancotti A, Quirino A, Pulicari          Tohoku J. Exp. Med. 2008; 216(1): 61-8.
     M, Zicca E, et al. Impact of interleukin-10, soluble
     CD25 and interferon-? on the prognosis and early                                                                          187
     diagnosis of bacteremic systemic inflammatory
     response syndrome: a prospective observational study.
     Crit Care. 2013; 17(2): R64.

76. Keel M, Härter L, Reding T, Sun L-K, Hersberger M,
     Seifert B, et al. Pancreatic stone protein is highly
     increased during posttraumatic sepsis and activates
     neutrophil granulocytes. Crit. Care Med. 2009; 37(5):
     1642–8.

77. Schuetz P, Müeller B. Procalcitonin in critically ill
     patients: time to change guidelines and antibiotic use
     in practice. Lancet Infect. Dis. 2016; 16(7): 758–60.

78. Rass AA, Talat MA, Arafa MA, El-Saadany HF,
     Amin EK, Abdelsalam MM, et al. The Role of
     Pancreatic Stone Protein in Diagnosis of Early Onset
     Neonatal Sepsis. Biomed. Res. Int. 2016; 1035856.

79. Keim V, Iovanna JL, Dagorn JC. The acute phase
     reaction of the exocrine pancreas. Gene expression
     and synthesis of pancreatitis-associated proteins.
     Digestion. 1994; 55(2): 65–72.

80. Llewelyn MJ, Berger M, Gregory M, Ramaiah R,
     Taylor AL, Curdt I, et al. Sepsis biomarkers in
     unselected patients on admission to intensive or high-
     dependency care. Crit. Care. 2013; 17:R60.

81. Graf R, Schiesser M, Reding T, Appenzeller P, Sun L-
     K, Fortunato F, et al. Exocrine meets endocrine:
     pancreatic stone protein and regenerating protein--two
     sides of the same coin. J. Surg. Res. 2006; 133(2):
     113–20.

82. Jin CX, Hayakawa T, Ko SBH, Ishiguro H, Kitagawa

      @Real Academia Nacional de Farmacia. Spain
   18   19   20   21   22   23   24   25   26   27   28